Developping a a Brain-controlled Art App to Ease Residual Symptoms of Depression (DEEPBLUE)

Centre Hospitalier Universitaire de Besancon

Status: Enrolling

Conditions: Depression

Treatments: Device: Neurofeedback sessions

Study type: Interventional

Funder types: Other

Identifiers

NCT06098469

API/2019/102

Details and patient eligibility

About

The study evaluate the effect of 10 neurofeedback sessions on the residual symptoms of depressive patients in partial remission.

Enrollment: 22 estimated patients

Sex: All

Ages: 25 to 65 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Subjects aged 25 to 65 included
• Information and signed informed consent
• Patients with a diagnosis of major depressive episode in remission
• MADRS score between 14 and 22
• Patients with residual symptoms as assessed by MADRS items
• No cognitive impairment.
• Right-handed

Exclusion criteria

• Subjects with legal incapacity or limited legal capacity
• Subjects unlikely to cooperate with the study and/or poor cooperation anticipated by the investigator
• Pregnant women
• Subjects in the exclusion period of another study or is on the "national volunteer list".
• Subjects with another psychiatric pathology (bipolar mood disorder, psychosis, obsessive-compulsive disorder, addictive pathology, schizophrenia)
• Subjects under a protective measure such as guardianship or safeguard of justice.

Trial design

Primary purpose: Treatment

Allocation: N/A

Interventional model: Single Group Assignment

Masking: None (Open label)

---

22 participants in 1 patient group

Neurofeedback

Experimental group

Description:

10 neurofeedback sessions + depressive rating scales

Treatment:

Device: Neurofeedback sessions